Different T cells' distribution and activation degree of Th17 CD4+ cells in peripheral blood in patients with osteoarthritis, rheumatoid arthritis, and healthy donors: preliminary results of the MAGENTA CLICAO study

Código QR

Different T cells' distribution and activation degree of Th17 CD4+ cells in peripheral blood in patients with osteoarthritis, rheumatoid arthritis, and healthy donors: preliminary results of the MAGENTA CLICAO study

Alfredomaria Lurati,1 Antonella Laria,1 Arianna Gatti,2 Bruno Brando,2 Magda Scarpellini1 1Rheumatology Unit, Fornaroli Hospital, Magenta, Italy; 2Transfusional Centre, Legnano Hospital, Legnano, Italy Objective: To determine distribution of T cells and activation degree of Th CD4+ cells in periphe...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Lurati A, Laria A, Gatti A, Brando B, Scarpellini M
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2015
Materias:	Diseases of the musculoskeletal system RC925-935
Acceso en línea:	https://doaj.org/article/e984753ea5964ad2ac36a232569c10e6
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Color duplex ultrasonography findings of temporal arteries in a case of giant cell arteritis: role in diagnosis and follow-up
por: Laria A, et al.
Publicado: (2017)

Improvement of HbA1c in Patients with Type 2 Diabetes Mellitus and Rheumatoid Arthritis Treated with bDMARDs
por: Lurati A, et al.
Publicado: (2021)

Rheumatoid arthritis: Disease or syndrome?
por: Jessica A Stanich, et al.
Publicado: (2009)

Certolizumab in the long-term treatment of rheumatoid arthritis
por: Scott DL, et al.
Publicado: (2011)

The pain-relieving qualities of exercise in knee osteoarthritis
por: Susko AM, et al.
Publicado: (2013)

Genetics of rheumatoid arthritis: GWAS and beyond
por: McAllister KM, et al.
Publicado: (2011)

Update on the use of rituximab for intractable rheumatoid arthritis
por: R John Looney
Publicado: (2009)

Optimal dose of etanercept in the treatment of rheumatoid arthritis
por: Curtis EM, et al.
Publicado: (2014)

Rheumatoid arthritis-associated interstitial lung disease
por: Brown KK, et al.
Publicado: (2012)

Long-term treatment of rheumatoid arthritis with adalimumab
por: Murdaca G, et al.
Publicado: (2013)

New and emerging therapies for the treatment of rheumatoid arthritis
por: Michael G Feely
Publicado: (2010)

New developments in the treatment of osteoarthritis – focus on biologic agents
por: Torrero JI, et al.
Publicado: (2015)

Goals for rheumatoid arthritis: treating to target or treating to prevent?
por: Yang M, et al.
Publicado: (2012)

Efficacy, safety, and tolerability of abatacept in the management of rheumatoid arthritis
por: Joseph R Lutt
Publicado: (2009)

Unique aspects of pain reduction in osteoarthritis of the knee with LMWF-5A
por: McGrath B
Publicado: (2015)

Prioritizing the patient: optimizing therapy in rheumatoid arthritis. Results of a patient questionnaire in northern Germany
por: Wollenhaupt J, et al.
Publicado: (2013)

Reappraisal of the clinical use of leflunomide in rheumatoid arthritis and psoriatic arthritis
por: Peter BB Jones, et al.
Publicado: (2010)

Obesity paradox in sarcopenia and knee osteoarthritis: comment on the article by Andrews et al
por: Kamal Mezian, et al.
Publicado: (2021)

The impact of tocilizumab on physical function and quality of life in patients with rheumatoid arthritis: a systematic literature review and interpretation
por: Townes SV, et al.
Publicado: (2012)

Critical appraisal of efficacy and safety of abatacept in the treatment of refractory rheumatoid arthritis
por: Augustine JM, et al.
Publicado: (2012)

Association of periodontitis with rheumatoid arthritis and atherosclerosis: Novel paradigms in etiopathogeneses and management?
por: Mena Soory
Publicado: (2010)

The use of administrative health care databases to identify patients with rheumatoid arthritis
por: Hanly JG, et al.
Publicado: (2015)

A measure of treatment response: patient and physician satisfaction with traditional NSAIDs for osteoarthritis control
por: Taylor SD, et al.
Publicado: (2013)

Association of Low Physical Activity Levels With Gait Patterns Considered at Risk for Clinical Knee Osteoarthritis Progression
por: Kerry E. Costello, et al.
Publicado: (2021)

Intra-articular Hyaluronic Acid for Osteoarthritis of the Knee in the United States: A Systematic Review of Economic Evaluations
por: Margaret Mordin, et al.
Publicado: (2021)

Patients’ Perceptions of Person‐Centered Care in Early Rheumatoid Arthritis: A Qualitative Study
por: Ellen Landgren, et al.
Publicado: (2021)

Tocilizumab, a humanized anti-interleukin-6 receptor antibody, for treatment of rheumatoid arthritis
por: Masahiko Mihara, et al.
Publicado: (2011)

Effects of low-dose tacrolimus therapy in combination with methotrexate in patients with methotrexate-refractory rheumatoid arthritis
por: Takeo Isozaki, et al.
Publicado: (2010)

Clinical efficacy of intra-articular injections in knee osteoarthritis: a prospective randomized study comparing hyaluronic acid and betamethasone
por: Trueba Davalillo CA, et al.
Publicado: (2015)

Serum anticyclic citrullinated protein antibody titers are correlated with the response to biological agents in patients with rheumatoid arthritis
por: Takahashi R, et al.
Publicado: (2014)

Correction to: Treatment response and several patient-reported outcomes are early determinants of future self-efficacy in rheumatoid arthritis
por: Michaël Doumen, et al.
Publicado: (2021)

Characterization of disease course and remission in early seropositive rheumatoid arthritis: results from the TACERA longitudinal cohort study
Publicado: (2021)

Efficacy of a natural mineral complex in North American adults with osteoarthritis of the knee: a randomized double-blind placebo-controlled study
por: Evans M, et al.
Publicado: (2014)

Involvement of CX3CL1/CX3CR1 axis in etanercept therapy for patients with active rheumatoid arthritis
por: Michihito Sato, et al.
Publicado: (2011)

Prevalence and risk factors of moderate to severe hepatic steatosis in patients with rheumatoid arthritis: an ultrasonography cross-sectional case–control study
por: Gian Luca Erre, et al.
Publicado: (2021)

Bioboosters in the treatment of rheumatic diseases: a comprehensive review of currently available biologics in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis
por: Fabrizio Cantini, et al.
Publicado: (2009)

The clinical efficacy and safety of certolizumab pegol (CZP) in the treatment of rheumatoid arthritis: focus on long-term use, patient considerations and the impact on quality of life
por: Roy Fleischmann
Publicado: (2009)

Incidence density of serious infection, opportunistic infection, and tuberculosis associated with biologic treatment in patients with rheumatoid arthritis &ndash; a systematic evaluation of the literature
por: Tran TN, et al.
Publicado: (2013)

Comparison of long-term efficacy between biological agents following tumor necrosis factor inhibitor failure in patients with rheumatoid arthritis: a prospective cohort study
por: Patricia Bogas, et al.
Publicado: (2021)

The crossbow sign in extracranial giant cell arteritis
por: Pierre‐Marie Duret, et al.
Publicado: (2021)